MONASH University's World Mosquito Program (WMP) has been awarded a further $50 million by the Wellcome Trust and the Bill & Melinda Gates Foundation.
The WMP uses Australian-developed technology to introduce naturally occuring Wolbachia into Aedes aegypti mosquitos to reduce their ability to transmit dengue, Zika and chikungunya.
Once released they breed with wild mosquitoes, passing on their ability to block the viruses.
The additional funding brings the joint contribution of the Trust and the Foundation to $185 million since 2010, with WMP director Scott O'Neill saying the Monash-led program is now operating in 12 countries worldwide.
"Thanks to this funding we're on track to having a really major impact on these mosquito-borne diseases globally," he said.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Aug 18
